Please use this identifier to cite or link to this item:
|Title:||β-amyloid 25-35 peptide reduces the expression of glutamine transporter SAT1 in cultured cortical neurons|
Tom Tallak Solbu
Farrukh A. Chaudhry
The Institute of Science and Technology for Research and Development, Mahidol University
Universitetet i Oslo
|Keywords:||Biochemistry, Genetics and Molecular Biology;Neuroscience|
|Citation:||Neurochemical Research. Vol.33, No.2 (2008), 248-256|
|Abstract:||β-Amyloid (Aβ) peptides may cause malfunction and death of neurons in Alzheimer's disease. We investigated the effect of Aβ on key transporters of amino acid neurotransmission in cells cultured from rat cerebral cortex. The cultures were treated with Aβ(25-35) at 3 and 10 μM for 12 and 24 h followed by quantitative analysis of immunofluorescence intensity. In mixed neuronal-glial cell cultures (from P1 rats), Aβ reduced the concentration of system A glutamine transporter 1 (SAT1), by up to 50% expressed relative to the neuronal marker microtubule-associated protein 2 (MAP2) in the same cell. No significant effects were detected on vesicular glutamate transporters VGLUT1 or VGLUT2 in neurons, or on glial system N glutamine transporter 1 (SN1). In neuronal cell cultures (from E18 rats), Aβ(25-35) did not reduce SAT1 immunoreactivity, suggesting that the observed effect depends on the presence of astroglia. The results indicate that Aβ may impair neuronal function and transmitter synthesis, and perhaps reduce excitotoxicity, through a reduction in neuronal glutamine uptake. © 2007 Springer Science+Business Media, LLC.|
|Appears in Collections:||Scopus 2006-2010|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.